-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Elevance Health, Raises Price Target to $460

Benzinga·05/22/2026 15:40:57
Listen to the news
UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $400 to $460.